Latest Funding News

Spacetalk Ltd reports robust growth in paid mobile subscribers and annual recurring revenue for Q2 FY25, underpinned by strategic international expansion and disciplined cost management.

Noble Helium has selected three initial drill sites in its North Rukwa Project in Tanzania, backed by significant helium detections and a flexible funding package including convertible notes and an equity facility. However, drilling has been deferred due to seasonal rains.

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Adisyn Ltd has successfully raised $10 million through a heavily oversubscribed placement, signaling strong institutional confidence in its graphene-enhanced semiconductor technology. The capital will accelerate development, commercial partnerships, and operational scaling.

Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.

Voltaic Strategic Resources has acquired a 4.2% shareholding in Geopacific Resources, gaining strategic exposure to the Woodlark Gold Project in Papua New Guinea, a well-capitalised development with a 12-year mine life and significant exploration upside.

Peako Limited reports compelling exploration results from its East Kimberley projects alongside the granting of new lithium-focused tenements and a successful $1.8 million capital raise.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.

Barton Gold Holdings reported a $1.74 million net cash outflow from operations in Q4 2024, ending the quarter with $7.01 million in cash and equivalents. The company’s available financing facilities and cash runway suggest cautious optimism for sustaining exploration activities.

Barton Gold Holdings reports a robust December quarter marked by a $5 million gold sale, extensive drilling at Tunkillia and Tarcoola projects, and a strong cash position heading into 2025.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.